Profile	GDS4460 / 231817_at
Title	Pimecrolimus and betamethasone valerate effects on lesional skin of actopic dermatitis
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM803586	patient 6, baseline	139	74
GSM803589	patient 7, baseline	221.8	80
GSM803592	patient 8, baseline	169	76
GSM803595	patient 10, baseline	183.8	77
GSM803598	patient 11, baseline	215.2	80
GSM803601	patient 12, baseline	220.8	80
GSM803604	patient 13, baseline	194.2	79
GSM803607	patient 14, baseline	203.3	79
GSM803610	patient 15, baseline	212.5	80
GSM803613	patient 16, baseline	125.1	72
GSM803587	patient 6, arm treated with pimecrolimus	177.9	77
GSM803590	patient 7, arm treated with pimecrolimus	296	84
GSM803593	patient 8, arm treated with pimecrolimus	210.8	79
GSM803605	patient 13, arm treated with pimecrolimus	118.3	71
GSM803608	patient 14, arm treated with pimecrolimus	191.8	78
GSM803599	patient 11, arm treated with pimecrolimus	165.8	76
GSM803611	patient 15, arm treated with pimecrolimus	230.6	81
GSM803614	patient 16, arm treated with pimecrolimus	228.2	81
GSM803602	patient 12, arm treated with pimecrolimus	209.9	80
GSM803596	patient 10, arm treated with pimecrolimus	206.6	79
GSM803591	patient 8, arm treated with betamethasone	169.5	76
GSM803609	patient 15, arm treated with betamethasone	132.7	72
GSM803597	patient 11, arm treated with betamethasone	158	75
GSM803585	patient 6, arm treated with betamethasone	163.8	76
GSM803603	patient 13, arm treated with betamethasone	204	79
GSM803612	patient 16, arm treated with betamethasone	151.1	74
GSM803588	patient 7, arm treated with betamethasone	323.8	85
GSM803594	patient 10, arm treated with betamethasone	193.9	78
GSM803600	patient 12, arm treated with betamethasone	158	75
GSM803606	patient 14, arm treated with betamethasone	318.1	85